Dr. Anthony Fauci, director of National Institute of Allergy and Infectious Diseases, expects to see data from the Phase 3 clinical trials of some COVID-19 vaccine candidates indicating whether the vaccines are safe and effective by "November or December" of this year. Fauci made the remarks while testifying during a congressional hearing on Wednesday. There are four experimental coronavirus vaccines in late-stage studies in the U.S., including candidates developed by AstraZeneca's (NAS:AZN) (LON:UK:AZN) and the University of Oxford, BioNTech (NAS:BNTX) and Pfizer Inc. (NYS:PFE) , Johnson & Johnson (NYS:JNJ) , and Moderna Inc. (NAS:MRNA) . "We feel strongly that if we have a combination of adherence to the public health measures together with a vaccine that will be distributed to people in this country and worldwide, we may be able to turn around this terrible pandemic that which we have been experiencing," he said. Drs. Robert Redfield, director for the Centers for Disease Control and Prevention, and Stephen Hahn, commissioner of the Food and Drug Administration, are also testifying.
Sept. 23, 2020, 10:52 a.m. EDT